Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | BMY | AMGN | MRNA | GILD |
| Company | Halozyme Therapeutic | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 38.98 | 49.00 | 270.63 | 111.05 | 66.58 |
| High | 39.70 | 49.04 | 274.86 | 111.29 | 67.18 |
| Low | 38.82 | 48.55 | 269.64 | 106.64 | 66.36 |
| Last | 39.12 | 48.86 | 273.01 | 108.85 | 67.08 |
| Change | +0.15 | -0.13 | -0.53 | +0.96 | +0.05 |
| % Change | +0.38% | -0.27% | -0.19% | +0.89% | +0.07% |
| Volume | 620,500 | 16,057,100 | 2,467,100 | 3,410,200 | 8,467,000 |
| 20-Day Average Volume | 868,775 | 11,259,110 | 2,172,705 | 3,227,110 | 6,490,535 |
| Previous Close | 38.97 | 48.99 | 273.54 | 107.89 | 67.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.49 | 50.37 | 271.55 | 105.22 | 69.07 |
| 20-Day Raw Stochastic | 35.92% | 18.15% | 44.22% | 62.73% | 14.81% |
| 20-Day Relative Strength | 49.23% | 41.15% | 48.18% | 56.47% | 33.12% |
| Weighted Alpha | +17.15 | -26.02 | +11.15 | -8.40 | -20.78 |
| Today's Opinion | 24% Buy | 88% Sell | 40% Sell | 88% Buy | 100% Sell |
| Previous Opinion | 24% Buy | 88% Sell | 40% Sell | 88% Buy | 100% Sell |
| Last Month's Opinion | 24% Buy | 8% Sell | 24% Buy | 72% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.89% since 04/17/24 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +5.23% since 04/17/24 | +0.22% since 04/17/24 |
| Low | 37.73 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 99.30 on 04/22/24 | 65.90 on 04/18/24 |
| High | 39.70 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 111.29 on 04/24/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -2.40% since 03/22/24 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | +3.24% since 03/22/24 | -7.62% since 03/22/24 |
| Low | 37.73 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.90 on 04/18/24 |
| High | 41.60 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | +11.61% since 01/24/24 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | +7.66% since 01/24/24 | -15.65% since 01/24/24 |
| Low | 33.15 on 02/05/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.90 on 04/18/24 |
| High | 42.64 on 03/13/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +12.25% since 10/24/23 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | +36.47% since 10/24/23 | -14.17% since 10/24/23 |
| Low | 32.83 on 10/25/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.90 on 04/18/24 |
| High | 42.82 on 12/14/23 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,970,353 | 99,027,448 | 146,436,016 | 41,676,488 | 83,519,768 |
| Shares Outstanding, K | 127,054 | 2,026,759 | 536,376 | 382,880 | 1,245,077 |
| Annual Sales | 829,250,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
| Annual Net Income | 281,590,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
| Last Quarter Sales | 230,040,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
| Last Quarter Net Income | 85,390,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.25 | 0.39 | 0.58 | 1.62 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.82 on 02/20/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/07/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 15.28 | 6.53 | 14.67 | 0.00 | 9.97 |